HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses

Structure‐guided stabilization of pathogen‐derived peptide‐HLA‐E complexes using non‐natural amino acids conserves native TCR recognition

(2022) Claire Barber et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease

(2022) José Manuel Martín-Villa et al.   Frontiers in Immunology

NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA‐E

(2022) Claire Battin et al.   IMMUNOLOGY

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes

(2022) Lucy C. Walters et al.   Cell Reports

Adaptive NK cell response to human cytomegalovirus: Facts and open issues

(2022) Miguel López-Botet et al.   SEMINARS IN IMMUNOLOGY

Human NK cells, their receptors and function

(2021) Linda Quatrini et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy

(2021) Marieke C. Verweij et al.   SCIENCE

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay

(2020) Lucy C. Walters et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia

(2019) Alexander Hallner et al.   BLOOD

Monalizumab: inhibiting the novel immune checkpoint NKG2A

(2019) Thorbald van Hall et al.   Journal for ImmunoTherapy of Cancer

ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution

(2019) Chuan Tian et al.   Journal of Chemical Theory and Computation

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study

(2019) Effie W Petersdorf et al.   Lancet Haematology

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells

(2018) Quirin Hammer et al.   NATURE IMMUNOLOGY

ElevatedHLA-Aexpression impairs HIV control through inhibition of NKG2A-expressing cells

(2018) Veron Ramsuran et al.   SCIENCE

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows

(2018) Thomas Partridge et al.   Frontiers in Immunology

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

(2018) Pascale André et al.   CELL

Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1

(2016) Wilfredo F Garcia-Beltran et al.   NATURE IMMUNOLOGY

Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E

(2016) S. G. Hansen et al.   SCIENCE

Building Water Models: A Different Approach

(2014) Saeed Izadi et al.   Journal of Physical Chemistry Letters

HLA Diversity in the 1000 Genomes Dataset

(2014) Pierre-Antoine Gourraud et al.   PLoS One

Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry

(2013) Loren Gragert et al.   HUMAN IMMUNOLOGY

HLA-B Signal Peptide Polymorphism Influences the Rate of HIV-1 Acquisition but Not Viral Load

(2012) Aimee M. Merino et al.   JOURNAL OF INFECTIOUS DISEASES

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

(2010) Brendan MacLean et al.   BIOINFORMATICS

Natural Killer Cell Education and Tolerance

(2010) Mark T. Orr et al.   CELL

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence

(2008) Emma J. Petrie et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Structural basis for NKG2A/CD94 recognition of HLA-E

(2008) B. K. Kaiser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA